Simulation of the optimal control P3 with <i>ω</i>₁ = 1, <i>ω</i>₂ = .5, <i>ω</i>₃ = 10 and <i>u</i>_<i>max</i> = 10. by Maria C. A. Leite (5586701)

HSC activation results in a preferential decrease in retinyl esters. by Nicole Testerink (169448)

SLE T cells display more genes with increased rather than decreased expression. by Sean J. Bradley (823158)

Wnt5a expressing tumors demonstrate a decrease in markers of the basal tumor subtype. by Stephanie L. Easter (662168)

Osteocyte-like cells isolated from <i>Hyp</i> mice display decreased <i>Tnap</i> mRNA expression together with PPi accumulation in vitro. by Sathish K. Murali (2585914)

Decreasing cell adhesion decreases [Ca²⁺]_i oscillation frequency. by Charles Godbout (540424)

Decreased capacity to infect is not correlated with a loss of metacyclic promastigotes. by Diana Moreira (186681)

Ketamine decreases NSC viability in a dose-dependent manner. by Shiva Mansouri (2838086)

Dynorphin Neuropeptides Decrease Apparent Proton Affinity of ASIC1a by Occluding the Acidic Pocket by Lilia Leisle (11356934)

Dynorphin Neuropeptides Decrease Apparent Proton Affinity of ASIC1a by Occluding the Acidic Pocket by Lilia Leisle (11356934)

Predicting Vulnerabilities of North American Shorebirds to Climate Change by Hector Galbraith (636637)

Protease treatment decreases binding of LGTV to A549 cells. by Raquel Rodrigues (221129)

A2M* decreases growth of tumour xenografts in mice. by Susanne Kurz (759116)

Presentation_1_Chronic Neurobehavioral Impairments and Decreased Hippocampal Expression of Genes Important for Brain Glucose Utilization in a Mouse Model of Mild TBI.PPTX by Linda M. Huynh (9395591)

“…There were no significant differences in NSS between injury and sham groups at any of the three time points. Thus, mTBI in male mice led to persistent decreased hippocampal expression of mRNAs that encode critical glucose utilization related enzymes in association with long-term impairments in selected neurobehavioral outcomes.…”

Pharmacologically induced torpor by 5′-AMP does not decrease platelet count despite decreased body temperature. by Edwin L. de Vrij (550179)

“…<p>A) Pharmacologically induced torpor by 5′-AMP in mice does not decrease platelet count during torpor and shows an increase upon arousal. …”

The <i>P[syt^P-L]</i> mutation decreases the Ca²⁺ affinity of release and vesicular release probability, but the readily releasable pool is unchanged. by Mallory C. Shields (4474210)

“…<p>(A) Mean EJP amplitudes from <i>+/-;P[syt^WT]/+</i> (filled black circles) and <i>+/-;P[syt^P-L]/+</i> (filled red circles) larvae at Ca²⁺ levels ranging from 0.05 mM—5.0 mM. …”

Tau phosphorylation is decreased in neurons treated with 20 mM KCl. by Nguyen-Vi Mohamed (323606)

“…<p>Immunoblot analysis of Tau phosphorylation in neurons treated either with 10mM or 20mM KCl. The phosphorylation of S199/S202, T181, T205 and S404 was not significantly affected by 10mM of KCl treatment whereas the phosphorylation of all these sites was decreased by 20mM of KCl treatment. …”

SinV infection causes a decrease in Neuro 2a cells number and viability. by Leandro Silva da Costa (327641)

Clinical outcome (3-month mean drop in HbA1c) by incentive group. by Leonard E. Egede (8097272)

The structures of T3 and Kylo-0603. by Xueqin lu (22250795)

Subjects: